Cellular immune profile in patients with non-small cell lung cancer after weekly paclitaxel therapy

Author： Sako Takanori   Burioka Naoto   Yasuda Kazuhito   Tomita Katsuyuki   Miyata Masanori   Kurai Jun   Chikumi Hiroki   Watanabe Masanari   Suyama Hisashi   Fukuoka Yasushi   Ueda Yasuto   Shimizu Eiji  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.43, Iss.1, 2004-03, pp. : 15-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I/II study of concurrent twice-weekly paclitaxel and weekly cisplatin with radiation therapy for stage III non-small cell lung cancer

By Solomon B.   Ball D.L.   Richardson G.   Smith J.G.   Millward M.   MacManus M.   Michael M.   Wirth A.   O'Kane C.   Muceniekas L.   Ryan G.   Rischin D.  

Lung Cancer, Vol. 41, Iss. 3, 2003-09 ,pp. : 353-361

Elsevier

Access to resources Recommend Favorite

Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

By Kalmadi Sujith   McNeill Giles   Davis Mellar   Peereboom David   Adelstein David   Mekhail Tarek  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 507-513

Humana Press, Inc

Access to resources Recommend Favorite

Measurement and impact of co-morbidity in elderly patients with advanced non-small cell lung cancer treated with chemotherapy. A phase II study of weekly paclitaxel

By Juan Oscar   Albert Ana   Campos Juan M.   Caranyana Vicente   Muñoz José   Alberola Vicente  

Acta Oncologica, Vol. 46, Iss. 3, 2007-01 ,pp. : 367-373

Informa Healthcare

Access to resources Recommend Favorite

A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer

By Kallab Andre   Nalamolu Yasolatha   Dainer Paul   Jillella Anand  

Medical Oncology, Vol. 22, Iss. 2, 2005-06 ,pp. : 145-151

Humana Press, Inc

Access to resources Recommend Favorite

Safety and efficacy of sequential chemotherapy with carboplatin plus gemcitabine followed by weekly paclitaxel in advanced non-small cell lung cancer

By Soetekouw Patricia   Timmer-Bonte Johanna   Drift Miep   Leeuwen Frank   Wagenaar Michiel   Die Lya   Bussink Jan   Tjan-Heijnen Vivianne  

International Journal of Clinical Oncology, Vol. 18, Iss. 6, 2013-12 ,pp. : 988-996

Springer Publishing Company

Access to resources Recommend Favorite